In this study, patients with higher serum syndecan-1 levels after completion of sepsis-associated DIC treatment were found to have elevated DIC scores and death, suggesting that serum syndecan-1 level may be a predictive marker for sepsis-associated DIC treatment. The gene discussed is SDC1; the disease is Sepsis.